Background:
One-piece implants allow to eliminate the prosthetic connection close to the crestal bone margin, reducing the bacterial microleakage and facilitating the management of the prosthetic manufacts.
Aim/Hypothesis:
Aim of this retrospective study was to assess interproximal bone stability around one piece transmucosal implants.
Material and Methods:
Between 2010 and 2014, 71 implants (Xive® TG, DENTSPLY Implants, Mannheim, Germany) were inserted in 22 patients (61 in the lower jaw, 10 in the maxilla). After a mean period of follow-up of 16 months, the evaluation of the bone stability was made with intraoral x-rays at the time of surgery (T0) and during the follow-up (T1). The reference point was represented the first implant thread.
Results:
No significant difference was showed comparing the interproximal bone level with the x-rays at T0 and T1. Only one implant had to be removed 1 month post-insertion, giving a cumulative survival rate of 98.6% for the 4-year study period.
Conclusions and clinical implications:
One piece transmucosal implants evidenced a real advantage in hard tissue remodeling, reducing or eliminate the bone resorption after the healing period. This retrospective study showed stable marginal bone levels, good soft tissue health, and a high implant survival rate, supporting the hypothesis that the presented one-piece implant system has the capacity to maintain both hard and soft tissues after the first year of initial bone remodelling.
Background:
One-piece implants allow to eliminate the prosthetic connection close to the crestal bone margin, reducing the bacterial microleakage and facilitating the management of the prosthetic manufacts.
Aim/Hypothesis:
Aim of this retrospective study was to assess interproximal bone stability around one piece transmucosal implants.
Material and Methods:
Between 2010 and 2014, 71 implants (Xive® TG, DENTSPLY Implants, Mannheim, Germany) were inserted in 22 patients (61 in the lower jaw, 10 in the maxilla). After a mean period of follow-up of 16 months, the evaluation of the bone stability was made with intraoral x-rays at the time of surgery (T0) and during the follow-up (T1). The reference point was represented the first implant thread.
Results:
No significant difference was showed comparing the interproximal bone level with the x-rays at T0 and T1. Only one implant had to be removed 1 month post-insertion, giving a cumulative survival rate of 98.6% for the 4-year study period.
Conclusions and clinical implications:
One piece transmucosal implants evidenced a real advantage in hard tissue remodeling, reducing or eliminate the bone resorption after the healing period. This retrospective study showed stable marginal bone levels, good soft tissue health, and a high implant survival rate, supporting the hypothesis that the presented one-piece implant system has the capacity to maintain both hard and soft tissues after the first year of initial bone remodelling.
Background:
One-piece implants allow to eliminate the prosthetic connection close to the crestal bone margin, reducing the bacterial microleakage and facilitating the management of the prosthetic manufacts.
Aim/Hypothesis:
Aim of this retrospective study was to assess interproximal bone stability around one piece transmucosal implants.
Material and Methods:
Between 2010 and 2014, 71 implants (Xive® TG, DENTSPLY Implants, Mannheim, Germany) were inserted in 22 patients (61 in the lower jaw, 10 in the maxilla). After a mean period of follow-up of 16 months, the evaluation of the bone stability was made with intraoral x-rays at the time of surgery (T0) and during the follow-up (T1). The reference point was represented the first implant thread.
Results:
No significant difference was showed comparing the interproximal bone level with the x-rays at T0 and T1. Only one implant had to be removed 1 month post-insertion, giving a cumulative survival rate of 98.6% for the 4-year study period.
Conclusions and clinical implications:
One piece transmucosal implants evidenced a real advantage in hard tissue remodeling, reducing or eliminate the bone resorption after the healing period. This retrospective study showed stable marginal bone levels, good soft tissue health, and a high implant survival rate, supporting the hypothesis that the presented one-piece implant system has the capacity to maintain both hard and soft tissues after the first year of initial bone remodelling.
Background:
One-piece implants allow to eliminate the prosthetic connection close to the crestal bone margin, reducing the bacterial microleakage and facilitating the management of the prosthetic manufacts.
Aim/Hypothesis:
Aim of this retrospective study was to assess interproximal bone stability around one piece transmucosal implants.
Material and Methods:
Between 2010 and 2014, 71 implants (Xive® TG, DENTSPLY Implants, Mannheim, Germany) were inserted in 22 patients (61 in the lower jaw, 10 in the maxilla). After a mean period of follow-up of 16 months, the evaluation of the bone stability was made with intraoral x-rays at the time of surgery (T0) and during the follow-up (T1). The reference point was represented the first implant thread.
Results:
No significant difference was showed comparing the interproximal bone level with the x-rays at T0 and T1. Only one implant had to be removed 1 month post-insertion, giving a cumulative survival rate of 98.6% for the 4-year study period.
Conclusions and clinical implications:
One piece transmucosal implants evidenced a real advantage in hard tissue remodeling, reducing or eliminate the bone resorption after the healing period. This retrospective study showed stable marginal bone levels, good soft tissue health, and a high implant survival rate, supporting the hypothesis that the presented one-piece implant system has the capacity to maintain both hard and soft tissues after the first year of initial bone remodelling.